Quick Answer
NANOVIRICIDES, INC. reported Stockholders Equity of $7.52 million for the year ending 2025.
- NANOVIRICIDES, INC. showed a decrease of -34.4% in Stockholders Equity from 2024 to 2025.
- This data is from NANOVIRICIDES, INC.'s annual report (Form 10-K), filed with the SEC on September 29, 2025.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2013: $10.21 million | Q1 2014: $27.95 million | Q3 2014: $36.83 million | Q1 2015: $31.86 million | Q3 2015: $30.71 million | Q4 2015: $28.38 million | Q1 2016: $23.98 million | Q3 2016: $20.23 million | Q4 2016: $19.15 million | Q1 2017: $22.41 million | Q3 2017: $18.52 million | Q4 2017: $15.92 million | Q1 2018: $19.15 million | Q3 2018: $15.98 million | Q4 2018: $13.84 million | Q1 2019: $12.72 million | Q3 2019: $9.13 million | Q4 2019: $7.72 million | Q1 2020: $14.31 million | Q3 2020: $29.98 million | Q4 2020: $27.75 million | Q1 2021: $31.89 million | Q3 2021: $28.31 million | Q4 2021: $26.47 million | Q1 2022: $24.76 million | Q3 2022: $21.56 million | Q4 2022: $19.87 million | Q1 2023: $18.23 million | Q3 2023: $12.97 million | Q4 2023: $12.45 million | Q1 2024: $10.65 million | Q2 2024: $11.46 million | Q3 2024: $10.11 million | Q4 2024: $10.39 million | Q1 2025: $8.83 million | Q2 2025: $7.52 million | Q3 2025: $7.17 million | Q4 2025: $11.07 million.
- Over the full 14 years of available data (2012 to 2025), NANOVIRICIDES, INC.'s Stockholders Equity has declined by 45.7%.
- Historical annual values: Fiscal year 2025: $7.52 million | Fiscal year 2024: $11.46 million | Fiscal year 2023: $14.87 million | Fiscal year 2022: $23.08 million | Fiscal year 2021: $29.91 million | Fiscal year 2020: $21.76 million | Fiscal year 2019: $10.60 million | Fiscal year 2018: $17.66 million | Fiscal year 2017: $20.32 million | Fiscal year 2016: $23.05 million | Fiscal year 2015: $31.79 million | Fiscal year 2014: $23.37 million | Fiscal year 2013: $8.01 million | Fiscal year 2012: $13.85 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: